Anti-Spike Mucosal IgA Protection against SARS-CoV-2 Omicron Infection

Uložené v:

Podrobná bibliografia
Vydané v:	The New England journal of medicine Ročník 387; číslo 14; s. 1333 - 1336
Hlavní autori:	Havervall, Sebastian, Marking, Ulrika, Svensson, Julia, Greilert-Norin, Nina, Bacchus, Philip, Nilsson, Peter, Hober, Sophia, Gordon, Max, Blom, Kim, Klingström, Jonas, Åberg, Mikael, Smed-Sörensen, Anna, Thålin, Charlotte
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	Massachusetts Medical Society 06.10.2022
Predmet:	Antibodies antibody detection antibody response controlled study Coronavirus coronavirus disease 2019 coronavirus spike glycoprotein correlation coefficient Correspondence COVID-19 cycle threshold value follow up health care personnel human Humans immunity immunoglobulin A immunoglobulin G immunology infection risk Letter major clinical study Neutralizing neutralizing antibody nonhuman polymerase chain reaction prevention and control risk reduction SARS-CoV-2 SARS-CoV-2 Omicron SARS-CoV-2 vaccine screening Spike Glycoprotein spike protein vaccinee Viral Viral Envelope Proteins virology virus antibody virus envelope protein virus replication
ISSN:	0028-4793, 1533-4406, 1533-4406
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!